Invesco
BNR

Invesco’s Burning Rock Biotech BNR Stock Holding History

Invesco’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,122
Closed -$110K – 3876
2023
Q2 		$110K Sell
5,122
-1,372
-21% -$36.4K ﹤0.01% 3708
2023
Q1 		$182K Sell
6,494
-430
-6% -$12.9K ﹤0.01% 3629
2022
Q4 		$156K Sell
6,924
-781
-10% -$17.8K ﹤0.01% 3755
2022
Q3 		$184K Buy
7,705
+192
+3% +$6.2K ﹤0.01% 3704
2022
Q2 		$219K Buy
7,513
+1,452
+24% +$64.8K ﹤0.01% 3697
2022
Q1 		$563K Buy
6,061
+2,281
+60% +$198K ﹤0.01% 3328
2021
Q4 		$360K Buy
3,780
+121
+3% +$16.6K ﹤0.01% 3530
2021
Q3 		$655K Buy
3,659
+1,127
+45% +$251K ﹤0.01% 3305
2021
Q2 		$746K Buy
2,532
+341
+16% +$101K ﹤0.01% 3255
2021
Q1 		$590K Buy
2,191
+849
+63% +$258K ﹤0.01% 3278
2020
Q4 		$310K Buy
+1,342
New +$360K ﹤0.01% 3405

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Invesco's BNR Position: Q3 2023 in Review

Invesco sold out of Burning Rock Biotech (BNR) in Q3 2023, closing a stake of 5,122 shares — an estimated $110K sold.

Invesco first reported a position in BNR in Q4 2020 and held it in 11 quarters. The position peaked at $746K in Q2 2021. 28 funds tracked by Wall St. Rank hold BNR as of Q3 2023.

  • Invesco reported no remaining Burning Rock Biotech position as of Q3 2023 after selling out during the quarter.
  • Invesco sold 5,122 Burning Rock Biotech shares in Q3 2023, an estimated $110K.
  • Invesco first reported a position in Burning Rock Biotech in Q4 2020 and held it in 11 quarters.
  • Invesco's Burning Rock Biotech position peaked at $746K in Q2 2021.
  • 28 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q3 2023.

Based on Invesco's 13F filing for Q3 2023, filed 13 Nov 2023.